Geron: Investing in the Promise of Stem Cell Technology

<p>When it comes to investing in new medical technologies, some of the most exciting and dynamic equities are companies that are involved in stem cell technology. There are several companies and firms that are working in the field of stem cells. Currently that number is roughly 300 entities engaged in the effort. Of those 300, only 2 companies have received the approval from the Food and Drug Administration..</p>